GLP-1 analog liraglutide protects against cardiac steatosis, oxidative stress and apoptosis in streptozotocin-induced diabetic rats

Medicine and Dentistry

• Liraglutide 100%
• Programmed Cell Death 85%
• Diabetes Mellitus 85%
• Oxidative Stress 71%
• Steatosis 71%
• Heart 57%
• Protein Kinase C 42%
• Glucagon Like Peptide 1 42%
• Streptozocin 42%
• Gene 28%
• Oxidoreductase 28%
• Marker 28%
• Glucose 28%
• Diacylglycerol 28%
• Lipid Metabolism 14%
• Triacylglycerol 14%
• Cardiovascular System 14%
• Plasma 14%
• Body Weight 14%
• Assay 14%
• TUNEL Assay 14%
• Lipid 14%
• Subcutaneous Injection 14%
• Oil 14%
• 8 Hydroxydeoxyguanosine 14%

Biochemistry, Genetics and Molecular Biology

• Liraglutide 100%
• Apoptosis 85%
• Oxidative Stress 71%
• Rat 57%
• Streptozotocin 42%
• Protein Kinase C 42%
• Nested Gene 28%
• Diacylglycerol 28%
• NAD(P)H Oxidase 28%
• Staining 28%
• Synthesis 14%
• Lipid Metabolism 14%
• Alpha Oxidation 14%
• Triglyceride 14%
• Glucose 14%
• Glucose Level 14%
• Lipid 14%
• Body Weight 14%
• Deoxyguanosine 14%
• Insulin Level 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Liraglutide 100%
• Diabetes Mellitus 85%
• Steatosis 71%
• Rat 57%
• Streptozotocin 42%
• Protein Kinase C 42%
• Glucagon-Like Peptide-1 42%
• Glucose 28%
• Oxidoreductase 28%
• Diacylglycerol 28%
• Oil 14%
• Insulin 14%
• Triacylglycerol 14%
• Lipid 14%
• Subcutaneous Injection 14%
• 8 Hydroxydeoxyguanosine 14%